HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jennifer L Wilkinson-Berka Selected Research

setanaxib

1/2018Effect of NADPH oxidase 1 and 4 blockade in activated human retinal endothelial cells.
7/2015Inhibition of NOX1/4 with GKT137831: a potential novel treatment to attenuate neuroglial cell inflammation in the retina.
6/2014NADPH oxidase, NOX1, mediates vascular injury in ischemic retinopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jennifer L Wilkinson-Berka Research Topics

Disease

18Retinopathy of Prematurity (Retrolental Fibroplasia)
01/2020 - 03/2003
18Diabetic Retinopathy (Retinopathy, Diabetic)
01/2020 - 01/2004
10Inflammation (Inflammations)
10/2019 - 01/2004
9Hypoxia (Hypoxemia)
01/2020 - 03/2003
8Hypertension (High Blood Pressure)
10/2019 - 01/2003
7Diabetic Nephropathies (Diabetic Nephropathy)
02/2004 - 01/2002
6Ganglion Cysts (Ganglion)
11/2017 - 09/2003
6Pathologic Neovascularization
06/2014 - 01/2006
4Retinal Neovascularization
01/2020 - 01/2006
4Gliosis
01/2016 - 01/2013
4Retinal Diseases
07/2015 - 01/2010
4Diabetes Complications
07/2015 - 01/2004
4Vascular System Injuries
07/2015 - 01/2013
4Fibrosis (Cirrhosis)
07/2004 - 01/2003
4Albuminuria
01/2004 - 03/2002
3Eye Diseases (Eye Disease)
01/2020 - 08/2005
3Vascular Diseases (Vascular Disease)
11/2018 - 07/2010
3Hyperoxia
01/2016 - 03/2003
2Leukostasis
01/2015 - 01/2009
1Bronchopulmonary Dysplasia
01/2020
1Respiratory Insufficiency (Respiratory Failure)
01/2020
1Lung Injury
01/2020
1Central Serous Chorioretinopathy
10/2019
1Experimental Diabetes Mellitus
11/2018
1Aneurysm (Aneurysms)
01/2018
1Aortic Rupture
01/2018
1Aortic Aneurysm (Aneurysm, Aortic)
01/2018
1Kidney Diseases (Kidney Disease)
01/2016
1Acute Lung Injury
01/2016
1Ischemia
07/2015
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
07/2015
1Necrosis
05/2015

Drug/Important Bio-Agent (IBA)

27Retinaldehyde (Retinal)IBA
01/2020 - 03/2003
13Oxygen (Dioxygen)IBA
01/2020 - 03/2003
12Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 09/2003
10Angiotensin IIIBA
10/2019 - 11/2002
9Messenger RNA (mRNA)IBA
01/2016 - 09/2003
7Reactive Oxygen Species (Oxygen Radicals)IBA
01/2020 - 07/2015
7Proteins (Proteins, Gene)FDA Link
01/2020 - 06/2002
7ReninIBA
05/2015 - 02/2003
6Streptozocin (Streptozotocin)FDA Link
08/2005 - 03/2002
5AntioxidantsIBA
01/2018 - 01/2013
5Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
07/2015 - 06/2010
5AngiotensinsIBA
01/2010 - 01/2004
4NADPH Oxidases (NAD(P)H oxidase)IBA
01/2020 - 06/2014
4Interleukin-6 (Interleukin 6)IBA
01/2020 - 01/2015
4Valsartan (Vals)FDA Link
01/2020 - 02/2007
4Protein Isoforms (Isoforms)IBA
01/2020 - 05/2013
4Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA
01/2020 - 01/2009
4AldosteroneIBA
10/2019 - 01/2009
4Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
07/2015 - 01/2009
3setanaxibIBA
01/2018 - 06/2014
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2016 - 01/2002
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2016 - 03/2012
3Transforming Growth Factor beta (TGF-beta)IBA
02/2003 - 01/2002
2Type 1 Angiotensin ReceptorIBA
01/2020 - 03/2012
2Cytochrome P-450 CYP11B2 (CYP11B2)IBA
01/2020 - 03/2012
2Chemotactic FactorsIBA
01/2020 - 03/2012
2Spironolactone (Aldactone)FDA LinkGeneric
01/2020 - 01/2009
2FadrozoleIBA
01/2020 - 03/2012
2CytokinesIBA
01/2020 - 01/2015
2CollagenIBA
01/2018 - 03/2002
2Oxidoreductases (Dehydrogenase)IBA
07/2015 - 03/2012
2Glutathione (Reduced Glutathione)IBA
07/2015 - 01/2013
2Prorenin ReceptorIBA
05/2015 - 07/2009
2Advanced Glycation End ProductsIBA
11/2013 - 12/2010
2candesartanIBA
12/2010 - 07/2004
2Insulin-Like PeptidesIBA
01/2006 - 08/2005
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
07/2004 - 03/2002
1Tissue Inhibitor of Metalloproteinase-1IBA
01/2020
1Superoxides (Superoxide)IBA
01/2020
1InterferonsIBA
01/2020
1cyclo(Trp-Asp-Pro-Val-Leu)IBA
11/2018
1Antihypertensive Agents (Antihypertensives)IBA
11/2018
1BQ 788IBA
11/2018
1Endothelins (Endothelin)IBA
11/2018
1AutoantigensIBA
01/2018
12- (2- chlorophenyl)- 4- methyl- 5- (pyridin- 2- ylmethyl)- 1H- pyrazolo(4,3- c)pyridine- 3,6(2H,5H)- dioneIBA
01/2018
1Endothelin-2IBA
01/2018
1Matrix Metalloproteinase 12IBA
01/2018
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2018
1Apolipoproteins E (ApoE)IBA
01/2018
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
01/2016
1SR1001IBA
01/2016
1Digoxin (Digitek)FDA LinkGeneric
01/2016
1Interleukin-17 (Interleukin 17)IBA
01/2016
1MicroRNAs (MicroRNA)IBA
01/2016
1Vascular Endothelial Growth Factor DIBA
01/2016
1CalciumIBA
07/2015
1Heme Oxygenase-1IBA
07/2015
1ebselenIBA
07/2015
1NitrogenIBA
07/2015
1Glutamate-Cysteine LigaseIBA
07/2015
1Glial Fibrillary Acidic ProteinIBA
07/2015
1dihydroethidiumIBA
07/2015
1B-Cell Activation Factor ReceptorIBA
07/2015
1NAD(P)H Dehydrogenase (Quinone) (Quinone Reductase)IBA
07/2015
1Interleukin-10 (Interleukin 10)IBA
05/2015
1Protective AgentsIBA
01/2015

Therapy/Procedure

1Intravitreal Injections
11/2018